Oliver-Krasinski, J. M., Bidot, S., Ingram, J. W., O’Toole, K. M., McKiernan, J. M., Tinsley, M., & Harik, L. R. (2023). Noninvasive Papillary Urothelial Carcinoma of the Bladder: An Institutional Experience Focusing on Tumors With Borderline Features. Archives of Pathology & Laboratory Medicine, 148(2), 223–229. https://doi.org/10.5858/arpa.2022-0268-oa

Chung, R., McKiernan, J., Arpaia, N., Marabelle, A., & Rouanne, M. (2023). Neo-Adjuvant immunotherapies: Bladder cancer as a platform for drug development targeting mucosal immunity. European Journal of Cancer, 187, 58–64. https://doi.org/10.1016/j.ejca.2023.03.037

Joshi, M., Tuanquin, L., Zhu, J., Walter, V., Schell, T., Kaag, M., Kilari, D., Liao, J., Holder, S. L., Emamekhoo, H., Sankin, A., Merrill, S., Zheng, H., Warrick, J., Hauke, R., Gartrel, B., Stein, M., Drabick, J., Degraff, D. J., & Zakharia, Y. (2023). Concurrent durvalumab and radiation therapy (DUART) followed by adjuvant durvalumab in patients with localized urothelial cancer of bladder: results from phase II study, BTCRC-GU15-023. Journal for ImmunoTherapy of Cancer, 11(2), e006551. https://doi.org/10.1136/jitc-2022-006551

Besharati, S., Liu‐Jarin, X., Chen, X., & Cimic, A. (2022). An unusual case of carcinoma with mesonephric‐like features with a spindle cell component diagnosed on the Pap test of the uterine cervix: Cytomorphologic and immunophenotypic features and diagnostic pitfalls. Diagnostic Cytopathology, 50(11). Portico. https://doi.org/10.1002/dc.25009

Gilbert, N. M., O’Brien, V. P., Waller, C., Batourina, E., Mendelsohn, C. L., & Lewis, A. L. (2022). Gardnerella Exposures Alter Bladder Gene Expression and Augment Uropathogenic Escherichia coli Urinary Tract Infection in Mice. Frontiers in Cellular and Infection Microbiology, 12. https://doi.org/10.3389/fcimb.2022.909799